BioAge Labs (BIOA) News
NASDAQ: BIOAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.28-0.43 (-9.13%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BIOA news summary
We found 2 recent headlines mentioning BioAge Labs (BIOA): 0 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. BIOA is making an outsized move today, down 9.13% at $4.28, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Weekly Buzz: RDY, LUPIN, SUNPHARMA Score FDA Wins; AGIO, RARE Slash Jobs; CVS Plots Split", was published by Nasdaq on Nov 6, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest BioAge Labs headlines
- Weekly Buzz: RDY, LUPIN, SUNPHARMA Score FDA Wins; AGIO, RARE Slash Jobs; CVS Plots Split(RTTNews) - The healthcare sector saw a busy week, with several companies securing regulatory approvals, announcing workforce restructuring, and advancing strategic business deals.NasdaqABT, AGIO, BEAT, BIOA
- BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business UpdatesFirst participant dosed in QUELL-DME, a Phase 2 trial of BGE-102, a potential best-in-class oral NLRP3 inhibitor, in diabetic macular edema; topline results anticipated in the second half of 2027GlobeNewswire